Description
A lignan; inhibits formation of AGEs in vitro; decreases escape latency in the Morris water maze and increases spontaneous alternation in the Y-maze in a mouse model of Alzheimer’s disease induced by amyloid-β (1-42) at 0.1 mg/kg; increases glial expression of GLP-1 and decreases immobility time in the FST in mice; increases spontaneous alternation in the Y-maze in a mouse model of stress-induced short-term learning impairment induced by the FST
Formal name: (2Z)-2-methyl-2-butenoic acid, (5S,6S,7S,13aS)-5,6,7,8-tetrahydro-6-hydroxy-1,2,3,13-tetramethoxy-6,7-dimethylbenzo[3,4]cycloocta[1,2-f][1,3]benzodioxol-5-yl ester
Synonyms: Gomisin B|Schizantherin B|Wuweizi ester B
Molecular weight: 514.6
CAS: 58546-55-7
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Natural Products|Lignans||Research Area|Neuroscience|Behavioral Neuroscience|Depression||Research Area|Neuroscience|Behavioral Neuroscience|Learning & Memory||Research Area|Neuroscience|Neurodegenerative Disorders|Alzheimer’s Disease